Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.
Interesting Engineering - First Ever HIV Immunotherapy Drug Proven Safe For Use in Humans
Latest News
The George Washington University (GW) Summer Program Advancing Research on Cancer (GW-SPARC) concluded its annual research immersion experience with a vibrant poster session on July 31.
Connor Perlin, a fourth-year student in the School of Medicine and Health Sciences MD program, is one of six George Washington University students and alumni named Fulbright grant recipients for 2025–26. Perlin received an Open Study/Research Award to conduct research in Slovenia beginning in…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) welcomed the MD Class of 2029 to the Foggy Bottom campus on July 30, launching their journey toward careers in medicine.